Elisa Tassinari

Via Albertoni-15
Bologna, 40138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?

Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?

Journal: Expert opinion on investigational drugs

Published: December 19, 2025

Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?

Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?

Journal: The Journal of pathology

Published: September 03, 2025

Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives.

Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives.

Journal: Discover oncology

Published: August 11, 2025

Leveraging targeted kinase degradation as a novel therapeutic strategy for Alzheimer's disease.

Leveraging targeted kinase degradation as a novel therapeutic strategy for Alzheimer's disease.

Journal: RSC medicinal chemistry

Published: July 31, 2025

Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma.

Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma.

Journal: Clinical genitourinary cancer

Published: June 05, 2025

AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease.

AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease.

Journal: European journal of medicinal chemistry

Published: April 08, 2025

Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges.

Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges.

Journal: Expert review of anticancer therapy

Published: March 16, 2025

The value of molecular features in predicting efficacy of immuno-combinations in kidney cancer: just a drop in the ocean?

The value of molecular features in predicting efficacy of immuno-combinations in kidney cancer: just a drop in the ocean?

Journal: Expert review of molecular diagnostics

Published: March 11, 2025

The Prognostic Role of 68GA-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer: A Preliminary Analysis.

The Prognostic Role of 68GA-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer: A Preliminary Analysis.

Journal: Clinical genitourinary cancer

Published: March 09, 2025

Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study.

Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study.

Journal: European urology focus

Published: March 08, 2025

Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience.

Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience.

Journal: Pathology, research and practice

Published: February 28, 2025

Dual-energy spectral CT in renal cell carcinoma: dawn of a brand-new era?

Dual-energy spectral CT in renal cell carcinoma: dawn of a brand-new era?

Journal: Expert review of molecular diagnostics

Published: February 14, 2025

Showing 1-12 of 42

Last Updated: 09/26/2026